Ambu A/S (CPH:AMBU.B)
88.30
-0.60 (-0.67%)
Nov 20, 2026, 11:25 AM CET
Ambu A/S Financials Overview
Financials in millions DKK. Fiscal year is October - September.
Millions DKK. Fiscal year is Oct - Sep.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Revenue Revenue Growth | 6,471 | 6,471 | 6,037 | 5,391 | 4,775 | 4,444 |
Revenue Growth | 7.19% | 7.19% | 11.98% | 12.90% | 7.45% | 10.74% |
Gross Profit Gross Profit Growth | 3,890 | 3,890 | 3,633 | 3,201 | 2,713 | 2,554 |
Operating Income Operating Income Growth | 851 | 851 | 784 | 645 | 302 | 122 |
Net Income Net Income Growth | 642 | 642 | 609 | 235 | 168 | 93 |
Earnings Per Share EPS Growth | 2.42 | 2.42 | 2.28 | 0.88 | 0.64 | 0.37 |
EPS Growth | 6.14% | 6.14% | 159.09% | 37.50% | 74.79% | -62.64% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Respiratory Respiratory Growth | 2,031 | 2,031 | 1,818 | 1,645 | 1,487 | 1,447 |
Urology (URO), Ear-Nose-Throat (ENT), and Gastroenterology (GI) Urology (URO), Ear-Nose-Throat (ENT), and Gastroenterology (GI) Growth | 2,095 | 2,095 | 1,826 | 1,545 | 1,200 | 877 |
Anesthesia Anesthesia Growth | 1,188 | 1,188 | 1,249 | 1,155 | 1,093 | 1,126 |
Patient Monitoring Patient Monitoring Growth | 1,157 | 1,157 | 1,144 | 1,046 | 995 | 994 |
Revenue (Total) Revenue (Total) Growth | 6,471 | 6,471 | 6,037 | 5,391 | 4,775 | 4,444 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Cash & Investments Cash & Investments Growth | 536 | 536 | 866 | 615 | 157 | 187 |
Total Debt Total Debt Growth | 593 | 593 | 547 | 558 | 584 | 1,845 |
Net Cash (Debt) Net Cash Growth | -57 | -57 | 319 | 57 | -427 | -1,658 |
Net Cash Growth | - | - | 459.65% | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -0.22 | -0.22 | 1.19 | 0.21 | -1.64 | -6.52 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 1,065 | 1,065 | 791 | 813 | 518 | 95 |
Capital Expenditures CapEx Growth | -204 | -204 | -117 | -88 | -71 | -138 |
Free Cash Flow Free Cash Flow Growth | 861 | 861 | 674 | 725 | 447 | -43 |
Free Cash Flow Growth | 27.74% | 27.74% | -7.03% | 62.19% | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
Gross Margin | 60.11% | 60.11% | 60.18% | 59.38% | 56.82% | 57.47% |
Operating Margin | 13.15% | 13.15% | 12.99% | 11.96% | 6.33% | 2.74% |
Pretax Margin | 12.98% | 12.98% | 12.51% | 5.56% | 4.40% | 2.45% |
Profit Margin | 9.92% | 9.92% | 10.09% | 4.36% | 3.52% | 2.09% |
FCF Margin | 13.31% | 13.31% | 11.16% | 13.45% | 9.36% | -0.97% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 |
|---|---|---|---|---|
| Period Ending | Nov '26 Nov 20, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 |
Dividend Per Share Dividend Per Share Growth | 0.560 | 0.560 | 0.410 | 0.380 |
Dividend Per Share Growth | 36.59% | 36.59% | 7.90% | - |
Dividend Yield | 0.63% | 0.81% | 0.44% | 0.29% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Nov '26 Nov 20, 2026 | Sep '26 Sep 30, 2026 | Sep '25 Sep 30, 2025 | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 |
PE Ratio | 36.49 | 28.04 | 40.51 | 148.67 | 117.08 | 181.46 |
Forward PE | 28.42 | 20.69 | 33.25 | 56.17 | 68.78 | 86.13 |
P/FCF Ratio | 26.91 | 20.91 | 36.60 | 48.19 | 44.00 | - |
PS Ratio | 3.58 | 2.78 | 4.09 | 6.48 | 4.12 | 3.80 |